[Nephrotic syndrome].
Sugiyama
Hitoshi
H
Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry.
Makino
Hirofumi
H
D000418:Albumins / Q000008:administration & dosage; D000818:Animals; D004039:Diet, Sodium-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D004232:Diuretics / Q000008:administration & dosage; D004487:Edema / Q000209:etiology / Q000628:therapy; D005665:Furosemide / Q000008:administration & dosage; D015433:Glomerulonephritis, Membranous / Q000209:etiology; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology; D006801:Humans; D007019:Hypoproteinemia / Q000188:drug therapy / Q000209:etiology; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D009402:Nephrosis, Lipoid / Q000209:etiology; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D011507:Proteinuria / Q000209:etiology
D000418:Albumins; D004044:Dietary Proteins; D004232:Diuretics; D007166:Immunosuppressive Agents; D005665:Furosemide; D011239:Prednisolone